ES2162638T3 - Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa. - Google Patents

Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa.

Info

Publication number
ES2162638T3
ES2162638T3 ES95931603T ES95931603T ES2162638T3 ES 2162638 T3 ES2162638 T3 ES 2162638T3 ES 95931603 T ES95931603 T ES 95931603T ES 95931603 T ES95931603 T ES 95931603T ES 2162638 T3 ES2162638 T3 ES 2162638T3
Authority
ES
Spain
Prior art keywords
eteres
pharmacos
gelification
cellulose
thermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95931603T
Other languages
English (en)
Inventor
Bhagwati P Kabra
John C Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of ES2162638T3 publication Critical patent/ES2162638T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTAN VEHICULOS PARA EL SUMINISTRO DE DROGAS QUE INCREMENTAN BIEN EL MODULO DE PERDIDA O BIEN EL MODULO DE ALMACENAMIENTO, O AMBOS, DESPUES DE SU CONTACTO CON EL OJO, LA PIEL, LA MEMBRANA MUCOSA, O UNA CAVIDAD CORPORAL. LOS VEHICULOS CONTIENEN UNO O MAS ETERES DE CELULOSA NO IONICOS, SUSTITUIDOS Y NO REQUIEREN UN SURFACTANTE CARGADO O UN POLIMERO SENSIBLE AL PH PARA EL INCREMENTO EN EL MODULO DE PERDIDA O EN EL MODULO DE ALMACENAMIENTO, O EN AMBOS, DESPUES DE SU ADMINISTRACION. EN UNA CONFORMACION, LOS VEHICULOS SE GELIFICAN DESPUES DE SU INSTALACION EN EL OJO.
ES95931603T 1994-08-30 1995-08-23 Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa. Expired - Lifetime ES2162638T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29824494A 1994-08-30 1994-08-30

Publications (1)

Publication Number Publication Date
ES2162638T3 true ES2162638T3 (es) 2002-01-01

Family

ID=23149679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95931603T Expired - Lifetime ES2162638T3 (es) 1994-08-30 1995-08-23 Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa.

Country Status (15)

Country Link
US (1) US5618800A (es)
EP (1) EP0725628B1 (es)
JP (1) JPH09508143A (es)
CN (1) CN1162148C (es)
AT (1) ATE208186T1 (es)
AU (1) AU686455B2 (es)
CA (1) CA2172373C (es)
DE (1) DE69523733T2 (es)
DK (1) DK0725628T3 (es)
ES (1) ES2162638T3 (es)
HK (1) HK1012558A1 (es)
MX (1) MX9601591A (es)
PT (1) PT725628E (es)
TW (1) TW460288B (es)
WO (1) WO1996006597A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19746264A1 (de) * 1997-10-20 1999-04-29 Wolff Walsrode Ag Verfahren zur Herstellung einer Carboxymethylcellulose mit verbesserter Wasserretention
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
ATE276199T1 (de) * 1999-02-03 2004-10-15 Biosante Pharmaceuticals Inc Methoden zur herstellung von therapeutische kalzium-phosphat partikeln
US6235893B1 (en) 1999-04-01 2001-05-22 The Dow Chemical Company Process for making cellulose ether having enhanced gel strength
JP2002541270A (ja) * 1999-04-01 2002-12-03 ザ ダウ ケミカル カンパニー 向上したゲル強度のメチルセルロース
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
DK1581162T3 (da) 1999-06-09 2011-08-01 Ethicon Inc Indretning til justering af polymerimplantater ved bløde overflader
US7121997B2 (en) 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
CA2386822A1 (en) 1999-11-01 2001-05-10 Alcon, Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
US7097855B1 (en) 2000-01-31 2006-08-29 Massachusetts Institute Of Technology Transdermal thermal polymerization
US7131943B2 (en) 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
ES2225573T3 (es) 2000-07-28 2005-03-16 Alcon, Inc Composiciones farmaceuticas que contienen tobramicina y goma xantana.
WO2002040056A2 (en) 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
WO2004006957A1 (en) * 2002-07-15 2004-01-22 Alcon, Inc. Pharmaceutical compositions for otic use
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
US20090041812A1 (en) * 2004-11-01 2009-02-12 Bell Steve J D Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use
EP1909703A4 (en) 2005-08-04 2011-01-12 Bard Inc C R SYSTEMS AND METHOD FOR BASE IMPLANTS
EP1948073B1 (en) 2005-11-14 2014-03-19 C.R.Bard, Inc. Sling anchor system
US20070142478A1 (en) * 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
US20070140897A1 (en) * 2005-12-21 2007-06-21 Hongna Wang Ph stable biguanide composition and method of treatment and prevention of infections
US20070141091A1 (en) * 2005-12-21 2007-06-21 Erning Xia Biguanide ointment and method of treatment and prevention of infections
US8480559B2 (en) 2006-09-13 2013-07-09 C. R. Bard, Inc. Urethral support system
DE102006062140A1 (de) * 2006-12-22 2008-06-26 Dow Wolff Cellulosics Gmbh Celluloseetheradditive für die Extrusion keramischer Massen
US20080161405A1 (en) * 2006-12-29 2008-07-03 Erning Xia Biguanide Composition and Method of Treatment and Prevention of Infections
US8206280B2 (en) 2007-11-13 2012-06-26 C. R. Bard, Inc. Adjustable tissue support member
DE102007059939A1 (de) 2007-12-12 2009-06-18 Müller-Schulte, Detlef, Dr. Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
US8449573B2 (en) 2008-12-05 2013-05-28 Boston Scientific Scimed, Inc. Insertion device and method for delivery of a mesh carrier
US8968334B2 (en) 2009-04-17 2015-03-03 Boston Scientific Scimed, Inc. Apparatus for delivering and anchoring implantable medical devices
US9301750B2 (en) 2009-11-03 2016-04-05 Boston Scientific Scimed, Inc. Device and method for delivery of mesh-based devices
GB201105408D0 (en) * 2011-03-30 2011-05-11 Glaxo Group Ltd Composition
KR101740300B1 (ko) * 2013-07-17 2017-05-26 다우 글로벌 테크놀로지스 엘엘씨 히드록시알킬 메틸셀룰로스를 포함하는 점막으로의 적용을 위한 조성물
EP3049060B1 (en) * 2013-09-25 2017-10-25 Dow Global Technologies LLC Composition for application to a mucosa comprising a cellulose ether
KR20180088274A (ko) * 2015-03-24 2018-08-03 다우 글로벌 테크놀로지스 엘엘씨 폴리머의 수용액
EP3331547A4 (en) 2015-08-05 2019-08-21 Children's Medical Center Corporation COMPOSITIONS WITH PERMEATION PROMOTERS FOR ACTIVE INJECTION
EP3512501A4 (en) * 2016-09-14 2020-04-29 Children's Medical Center Corporation COMPOSITIONS WITH PERMEATION AMPLIFIERS FOR MEDICATION RELEASE

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3767788A (en) * 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
SE403782B (sv) * 1973-03-14 1978-09-04 Mo Och Domsjoe Ab Nonjoniska cellulosaetrar
US4001211A (en) * 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
CS180191B1 (en) * 1974-12-04 1977-12-30 Arnost Kotik Tube shape heat exchanger with internal ribbing
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3700681A1 (de) * 1987-01-12 1988-07-21 Breveteam Sa Sphaerisches faseraggregat, insbesondere als fuell- oder polstermaterial
SE461396B (sv) * 1988-05-24 1990-02-12 Berol Kemi Ab Saett att vid temperaturhoejning motverka viskositetsnedgaang alternativt aastadkomma viskositetsoekning hos ett vattenbaserat system innehaallande en polymer som viskositetsgivare
US5279660A (en) * 1988-05-24 1994-01-18 Berol Nobel Stenungsund Ab Use of viscosity-adjusting agent to counteract viscosity decrease upon temperature increase of a water-based system
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5306501A (en) * 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5296228A (en) * 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5470881A (en) * 1993-09-09 1995-11-28 West Virginia University Research Corporation Urea ophthalmic ointment and solution

Also Published As

Publication number Publication date
TW460288B (en) 2001-10-21
ATE208186T1 (de) 2001-11-15
PT725628E (pt) 2002-03-28
US5618800A (en) 1997-04-08
AU686455B2 (en) 1998-02-05
DE69523733D1 (de) 2001-12-13
DE69523733T2 (de) 2002-08-01
CN1134662A (zh) 1996-10-30
JPH09508143A (ja) 1997-08-19
DK0725628T3 (da) 2001-12-27
CN1162148C (zh) 2004-08-18
AU3496595A (en) 1996-03-22
CA2172373C (en) 1999-03-16
WO1996006597A1 (en) 1996-03-07
HK1012558A1 (en) 1999-08-06
EP0725628A1 (en) 1996-08-14
EP0725628B1 (en) 2001-11-07
CA2172373A1 (en) 1996-03-07
MX9601591A (es) 1997-05-31

Similar Documents

Publication Publication Date Title
ES2162638T3 (es) Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa.
TWI262797B (en) Gelling ophthalmic compositions containing xanthan gum
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
USD295445S (en) Combined punctum plug dilator and inserter for treating dry eye or other ophthalmic ailments
ES2089930T3 (es) Gel acuoso de maquillaje con organopolisiloxano.
PT1028707E (pt) Formulacoes oftalmicas de libertacao controlada contendo medicamentos soluveis em agua
ATE203897T1 (de) Konservierungsmittelhaltige ophtalmisch anzuwendende arzneizusammensetzungen enthaltend quaternäre polymerammoniumverbindungen
AU4718297A (en) Improvements in or relating to diagnostic/therapeutic agents
ES2184306T3 (es) Soluciones de acondicionamiento para el cuidado de las lentes de contacto duras.
EP0640647A3 (en) Ion-crosslinked glycosaminoglycan gels to increase soft tissue and for drug delivery.
PT946143E (pt) Composicao gelificada a base de nitro-imidazole.
MX9803897A (es) Enzimas con puntos isoelectricos bajos para usarse en limpieza de lentes de contacto.
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
ATE240094T1 (de) Ophthalmische zusammensetzungen in form wässriger gele
ATE191845T1 (de) Pharmazeutische träger zur topischen ophthalmischen anwendung
ES2195319T3 (es) Composicion edulcurante soluble cob inulina.
ES2177787T3 (es) Uso de hidroxietil-almidon para evitar la formacion de adhesiones post-operatorias y como dispositivo de barrera intra-cavidades.
DE69006172D1 (de) Breitbandiger optischer Verstärker mit aktiver Faser.
BR9711559A (pt) Gel antimicÄtico com elevada libera-Æo de subst ncia de subst ncia ativa
BG104825A (en) Ophthalmic solution comprising glycogen
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
EP1230918A3 (en) An aqueous enteroclysis solution for the treatment of hepatic encephalopathy
ES2087863T3 (es) Composicion limpiacristales.
ES8605906A1 (es) Un procedimiento para la preparacion de nuevos copolimeros estadisticos de vinil-pirrolidona.
CA2130988A1 (en) Pharmaceutical Composition for Treatment of Sudden Deafness

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 725628

Country of ref document: ES